Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 3,367,064 | reported | 04 Mar 2026 | tx 74+12,048,268−1,981,928 |
| Zynerba Pharmaceuticals, Inc. | 47,824 | reported | 10 Oct 2023 | tx 17+274,832−187,332 |
| KERYX BIOPHARMACEUTICALS INC | 30,000 | reported | 09 Jun 2017 | tx 4+80,000 |
| Relypsa Inc | 0 | reported | 01 Sept 2016 | tx 16+44,672−44,672 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | PURCHASE | Akebia Therapeutics, Inc. | 69,270 | 1.25 USD | first after silence |
| 02 Feb 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 175,250 | 1.41 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 83,689 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 114,891 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 96,065 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 46,660 | 1.39 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 743,000 | 0.00 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 1,115,000 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Akebia Therapeutics, Inc. | 46,409 | 1.83 USD | |
| 03 Feb 2025 | SALE | Akebia Therapeutics, Inc. | 46,268 | 2.10 USD | |
| 03 Feb 2025 | SALE | Akebia Therapeutics, Inc. | 97,982 | 2.10 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 701,000 | 0.00 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 1,051,400 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 350,500 | 0.00 USD | deriv |
| 29 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 46,570 | 1.58 USD | |
| 27 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 37,733 | 1.52 USD | |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 603,500 | 0.00 USD | |
| 01 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 46,489 | 1.68 USD | |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 905,200 | 0.00 USD | deriv |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 32,941 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 47,824 | — | |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 34,663 | — | deriv |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 71,736 | — | deriv |
| 14 Jun 2023 | SALE | Zynerba Pharmaceuticals, Inc. | 115 | 0.35 USD | anomaly |
| 13 Jun 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 47,824 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 04 Mar 2026.